Mucinex All in One Fast Max, Cold and Flu Medicine, Day & Night Combo Pack, 2x6 fl oz
$11.22 ( In Stock ) ( left ) ( out of stock )
-
Description
Maximum Strength Mucinex Fast-Max Cold & Flu and Mucinex NightShift Maximum Strength Severe Cold & Flu Day Night Combo pack is a Multi-Symptom Relief medicine and All-in-One solution for Cold & Flu symptoms. Fast-Max Cold & Flu liquid help reduce Fever, relieves Cough, Nasal congestion, Body pain, Sore Throat, Chest Congestion, Sinus Pressure & Congestion, Headache. NightShift liquid reduce Fever, relieves Cough, Nasal Congestion, Body pain, Sore Throat, Itchy Throat, Runny Nose, Sneezing and Headache. Mucinex is the #1 Cough & Cold Brand Doctors Trust* and #1 Pharmacist Recommended Brand† as well. This product contains two 6 FL OZ bottles. It can be consumed by Adults and Children aged 12 years and above.MULTI-SYMPTOMS ALLEVIATEDDAY TIME SYMPTOMS ALLEVIATED: Mucinex Fast-Max Cold & Flu is All-in-One solution to relieve 9 symptoms - Fever, Cough, Nasal Congestion, Body pain, Sore Throat, Chest congestion, Sinus pressure, Sinus congestion and HeadacheNIGHT TIME SYMPTOMS ALLEVIATED: Mucinex Night Shift Severe Cold & Flu is All-in-One solution to relieve 9 symptoms - Fever, Cough, Nasal Congestion, Body pain, Sore Throat, Itchy Throat, Runny nose, Sneezing and HeadacheKEY INGREDIENTSFAST-MAX COLD & FLU ACTIVE INGREDIENTS (DAY): Contains Acetaminophen - pain reliever and fever reducer; Dextromethorphan HBr - cough suppressant; Guaifenesin - expectorant/thins and loosens mucus; Phenylephrine HCI - nasal decongestantNIGHTSHIFT SEVERE COLD & FLU ACTIVE INGREDIENTS (NIGHT): Contains Acetaminophen - pain reliever and fever reducer; Dextromethorphan HBr - cough suppressant; Phenylephrine HCI - nasal decongestant; Triprolidine HCl – Antihistamine to alleviate sneezing, runny and itchy nose and watery eyesDo not take Mucinex Fast-Max Cold & Flu and Mucinex Nightshift Severe Cold & Flu at the same time. Always wait at least 4 hours before taking another dose of Mucinex liquid. TAKE ONLY AS DIRECTED.*IQVIA using ProVoice Survey, December 2022†U.S. News & World Report/Pharmacy Times 2023-2024
-
reviews
{{review.author|getFirstChar}}
{{review.author}} on {{review.pub_time}} {{review.title}} {{review.content}} {{ text }} Write ReviewScore*{{reviewStar}}Your Name:please enter your nameYour Email:please enter the right EmailReview Title:please enter titleReviewplease enter your review